Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - SHORT-TERM DEBT
Short-term Debt EBS - Emergent BioSolutions Inc.
414 M
LAST VALUE
261.83%
2 YEAR CAGR
110.12%
5 YEAR CAGR
0.00%
10 YEAR CAGR